NPPA Revises Ceiling Price of 4 Scheduled Formulation, Detail Dr. Divya Colin23 Aug 2024 6:00 PM ISTNew Delhi: Through a recent notice, after considering the Wholesale Price Index (WPI) impact at 0.00551% for the year 2024, the National...
156 FDCs banned with immediate effect, declared irrational: Ministry of Health and Family Welfare Ruchika Sharma22 Aug 2024 6:00 PM ISTNew Delhi: Citing that there is no therapeutic justification for the ingredients contained in fixed dose combinations (FDC) and that the FDC may...
Shri Arunish Chawla assigned to additional role of Chairman, National Pharmaceuticals Pricing Authority Dr. Divya Colin21 Aug 2024 6:00 PM ISTNew Delhi: In a recent notice, the Department of Pharmaceuticals, the Ministry of Chemicals and Fertiliser, the National Pharmaceutical Pricing...
NPPA Fixes Retail Prices of 70 Formulations, Details Dr. Divya Colin20 Aug 2024 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, the Government of...
Submit diagnosis criteria for lower respiratory infection and earlier study data: CDSCO Panel Tells Pfizer on Sisunatovir capsule Dr. Divya Colin19 Aug 2024 6:00 PM ISTNew Delhi: Reviewing the Phase 1b clinical study protocol for Sisunatovir 50 mg capsules, the Subject Expert Committee (SEC) functional under the...
Increase sample size for immunogenicity analysis for booster dose: CDSCO Panel Tells Biological E on PCV-14 Vaccine Dr. Divya Colin18 Aug 2024 6:00 PM ISTNew Delhi: Reviewing the amended Phase IV clinical trial protocol of Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) (14-valent) [PCV-14]...
Bristol Myers Squibb India Gets CDSCO Panel Nod to Study anticancer drug Mezigdomide Dr. Divya Colin17 Aug 2024 6:00 PM ISTNew Delhi: The drug major Bristol-Myers Squib has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Hetero Labs Gets CDSCO Panel Nod to Study Tedizolid Phosphate for Acute Bacterial Skin and Skin Structure Infections Dr. Divya Colin16 Aug 2024 6:00 PM ISTNew Delhi: Hetero Labs has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Zydus Lifscience Gets CDSCO Panel Nod to Study Measles and Rubella Vaccine Dr. Divya Colin15 Aug 2024 6:00 PM ISTNew Delhi: The drug major Zydus Lifscience has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Serum Institute of India Gets CDSCO Panel Nod To study Meningococcal Polysaccharide Conjugate Vaccine Freeze-Dried Dr. Divya Colin14 Aug 2024 6:00 PM ISTNew Delhi: The vaccine major Serum Institute of India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug...
Intas Pharmaceuticals Gets CDSCO Panel Nod to Study Vedolizumab for Ulcerative Colitis Dr. Divya Colin13 Aug 2024 6:00 PM ISTNew Delhi: Intas Pharmaceuticals has got the go-ahead from the Subject Expert Committee ( SEC) functional under the Central Drug Standard Control...
Submit Immunogenicity Data: CDSCO Panel Tells Pfizer on Pneumococcal Polysaccharide Conjugate Vaccine study Dr. Divya Colin12 Aug 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial report of the 20 valent Pneumococcal Conjugate Vaccine (20vPnC) presented by Pfizer, the Subject...
